Combination 5FU and oxaliplatin chemotherapy was found to increase MUC5AC expression in a dose-dependent manner in CRC cell lines and cells expressing MUC5AC had greater viability when compared to MUC5AC knockout cells. This evidence concerns the gene MUC5AC and colorectal carcinoma.